
Antivenom
Incepta Pharmaceuticals Ltd.
Snake Venom Antiserum is a passive immunization biologic indicated for the emergency treatment of confirmed or strongly suspected venomous snakebite envenomation.
Snake Venom Antiserum is a passive immunization biologic indicated for the emergency treatment of confirmed or strongly suspected venomous snakebite envenomation.
Dosing of Snake Venom Antiserum is determined by the treating physician based on the clinical severity of envenomation, not on patient body weight, and must follow local/national snakebite management guidelines.
| Severity of Envenomation | Initial Dose (typical range) | Notes |
|---|---|---|
| Mild/moderate systemic envenomation | Typically 5-10 vials (per local protocol/product potency) | Reassess clinically and with clotting tests after 1-2 hours; repeat dose if no improvement |
| Severe envenomation (e.g., major bleeding, shock, marked neurotoxicity) | Higher initial dose (e.g., 10-20 vials or per local protocol) | Give as an initial rapid but controlled intravenous infusion under continuous monitoring |
| Pediatric patients | Same vial dose as adults for the same degree of envenomation | Dose is NOT reduced for children; envenomation severity, not body weight, determines the dose |
Exact vial numbers vary by product potency/brand and local treatment protocol; always follow the specific product's package insert and the national snakebite treatment guideline in use.
Any reaction during or after administration of Snake Venom Antiserum requires prompt medical evaluation.
There are no true absolute contraindications to Snake Venom Antiserum in a patient with life-threatening or clinically significant snakebite envenomation, because the risk of untreated severe envenomation generally outweighs the risk associated with the antiserum itself.
A known severe prior anaphylactic reaction to the same antiserum is not an absolute contraindication when envenomation is life-threatening, but it requires extreme caution, senior physician involvement, premedication, and full resuscitation readiness (see Precautions and Warnings) before re-administration of Snake Venom Antiserum.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.